Insulin aspart, recombinant Subcutaneous and Mesna Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Mesna Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: mesna
Brand name: Mesnex
Synonyms: Mesna (oral/injection), Mesna
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Mesna oral/injection
- Insulin aspart, recombinant Subcutaneous-Mesna Tablets
- Insulin aspart, recombinant Subcutaneous-Mesnex
- Insulin aspart, recombinant Subcutaneous-Mesnex (Mesna Injection)
- Insulin aspart, recombinant Subcutaneous-Mesnex (Mesna Tablets)
- Insulin aspart, recombinant Subcutaneous-Mesnex Injection
- Mesna Intravenous-Insulin degludec
- Mesna Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Mesna Intravenous-Insulin Degludec (U-100) Vials
- Mesna Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Mesna Intravenous-Insulin degludec and liraglutide
- Mesna Intravenous-Insulin degludec and liraglutide Subcutaneous